patents Archives

Pharmalot Ed Silverman

ViiV will make it easier for generic companies to copy its HIV prevention shot, but it’s not clear when

Pharmalot Ed Silverman

Alnylam sues Pfizer and Moderna for patent infringement in development of Covid-19 vaccines

Pharmalot Ed Silverman

A battle is brewing between a senator and a nonprofit over pharma patenting practices

Pharmalot Ed Silverman

Moderna will never enforce Covid-19 vaccine patents in poor countries

First Opinion Tahir Amin and Priti Krishtel

Solving the U.S. drug pricing crisis starts with a crucial confirmation hearing

Opinions+ Andrei Iancu and David Kappos

Why does the FDA want to stop improving medicines via patent ‘areas of concern’?

Pharmalot Ed Silverman

U.S. lawmakers accuse patent office of weakening challenges and allowing drug prices to rise

Pharmalot Ed Silverman

Advocates urge Biden to name patent office director that could transform drug pricing

Pharmalot Ed Silverman

Moderna vows not to enforce Covid-19 patents, but advocates say IP should be given to WHO

Pharmalot Ed Silverman

Consumer groups and unions urge FTC to block AbbVie and Allergan merger

Pharmalot Ed Silverman

Pharmalittle: Judge appears to back push for opioid settlement; the CRISPR patent fight lives on

First Opinion Othman Laraki

Proposed patent legislation would block research, stifle innovation, and harm patients

Pharmalot Ed Silverman

FTC says pay-to-delay cases fell, prompting trade group to argue legislation isn’t needed

Pharmalot Ed Silverman

Baltimore sues a J&J unit over ‘sham’ patent litigation to extend its monopoly on a cancer drug

Pharmalot Ed Silverman

Pharmalittle: Surprise FDA approval may dampen storm over pricey drug; should the U.S. adopt reference pricing?

Pharmalot Ed Silverman

Pharmalittle: NAFTA deal may hinge on patent protections for drugs; House committee goes after Sacklers

Pharmalot Ed Silverman

Pharmalittle: Allergan depression drug fails three trials; Vertex CEO appears before Parliament

Pharmalot Ed Silverman

Bristol-Myers faces growing opposition to its Celgene deal. Here’s what the wags are saying

Pharmalot Ed Silverman

AbbVie must fork over Humira documents after judge slams a ‘nonsense’ argument

Pharmalot Ed Silverman

Pharmalittle: Drug makers to raise prices in January; Novartis names a new oncology chief, again

Pharmalot Ed Silverman

Trump administration report would preclude reclaiming patents as a way to lower drug prices

Pharmalot Ed Silverman

Pharmalittle: Retail drug spending in the U.S. fell last year; Democrats eye patents to lower drug prices

Pharmalot Ed Silverman

Supreme Court to decide a patent case with big implications for small drug makers

Pharmalot Ed Silverman

Pharmalittle: AbbVie cancer program’s setback; Amazon hires a pharmacy expert

Pharmalot Ed Silverman

patents

Most Read

Oxfam wants the SEC to investigate Moderna for ‘misleading’ investors about its Covid patent dispute with NIH

AbbVie asks the U.S. International Trade Commission to investigate Alvotech’s plans for a biosimilar Humira

Facing intense criticism, Moderna pauses bitter dispute with the NIH over Covid-19 vaccine patents

Patent reform is needed to protect patients’ access to lifesaving drugs

We need a Public Domain Day to highlight when drugs go off patent

Regeneron CEO: ‘We need a carrot-and-stick system’ to balance pricing and innovation

Listen: Episode 16: To make big profits, drug companies turn to monopoly shenanigans

Lies, damn lies, and CRISPR: the legal battle escalates

All Coverage

ViiV will make it easier for generic companies to copy its HIV prevention shot, but it’s not clear when

Alnylam sues Pfizer and Moderna for patent infringement in development of Covid-19 vaccines

A battle is brewing between a senator and a nonprofit over pharma patenting practices

Moderna will never enforce Covid-19 vaccine patents in poor countries

Solving the U.S. drug pricing crisis starts with a crucial confirmation hearing

Why does the FDA want to stop improving medicines via patent ‘areas of concern’?

U.S. lawmakers accuse patent office of weakening challenges and allowing drug prices to rise

Advocates urge Biden to name patent office director that could transform drug pricing

Moderna vows not to enforce Covid-19 patents, but advocates say IP should be given to WHO

Consumer groups and unions urge FTC to block AbbVie and Allergan merger

Pharmalittle: Judge appears to back push for opioid settlement; the CRISPR patent fight lives on

Proposed patent legislation would block research, stifle innovation, and harm patients

FTC says pay-to-delay cases fell, prompting trade group to argue legislation isn’t needed

Baltimore sues a J&J unit over ‘sham’ patent litigation to extend its monopoly on a cancer drug

Pharmalittle: Surprise FDA approval may dampen storm over pricey drug; should the U.S. adopt reference pricing?

Pharmalittle: NAFTA deal may hinge on patent protections for drugs; House committee goes after Sacklers

Pharmalittle: Allergan depression drug fails three trials; Vertex CEO appears before Parliament

Bristol-Myers faces growing opposition to its Celgene deal. Here’s what the wags are saying

AbbVie must fork over Humira documents after judge slams a ‘nonsense’ argument

Pharmalittle: Drug makers to raise prices in January; Novartis names a new oncology chief, again

Trump administration report would preclude reclaiming patents as a way to lower drug prices

Pharmalittle: Retail drug spending in the U.S. fell last year; Democrats eye patents to lower drug prices

Supreme Court to decide a patent case with big implications for small drug makers

Pharmalittle: AbbVie cancer program’s setback; Amazon hires a pharmacy expert

Boehringer Ingelheim abandons biosimilar sales outside the U.S.

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day